Pfizer Points to Waning Immunity in Need for Booster Shots

Pfizer Points to Waning Immunity in Need for Booster Shots

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the safety and effectiveness of COVID-19 booster shots, highlighting the complexity of immunity fading and the role of boosters in raising antibody levels. It compares the UK and US approaches to booster distribution, emphasizing the need for caution in younger populations and addressing global vaccine equity.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the simple view of booster shots mentioned in the video?

They are safe and effective against the virus.

They are harmful and should be avoided.

They are unnecessary and ineffective.

They are only for older people.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What evidence is there regarding the decline of immunity over time?

Immunity decline is only a concern in the US.

Evidence from Israel and the UK shows a decline in protection against infection.

Immunity decline is only observed in children.

There is no evidence of immunity decline.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which population is most affected by the decline in immunity according to the video?

Young children

Teenagers

Middle-aged adults

Older people

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the UK's approach to booster shots for people over 50?

They are only offering booster shots to healthcare workers.

They are offering booster shots starting next week.

They are not offering booster shots at all.

They are waiting for more data before offering booster shots.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is it suggested to wait before giving booster shots to younger people?

To ensure older people receive them first.

To wait for more data and address vaccine equity.

Because younger people do not need vaccines.

To save costs on vaccine production.